Seegene, Inc. (KOSDAQ:096530)
South Korea flag South Korea · Delayed Price · Currency is KRW
32,000
-550 (-1.69%)
Jul 18, 2025, 3:30 PM KST

Seegene Company Description

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide.

It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products.

The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes.

The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Seegene, Inc.
CountrySouth Korea
Founded2000
IndustryMedical - Specialties
SectorHealthcare
Employees63
CEOJong-Yoon Chun

Contact Details

Address:
Taewon Building
Seoul, 05548
South Korea
Phone82 2 2240 4000
Websiteseegene.com

Stock Details

Ticker Symbol096530
ExchangeKOSDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
ISIN NumberKR7096530001
SIC Code2835

Key Executives

NamePosition
Jong-Yoon ChunChief Executive Officer